Emergent Biosolutions(CH:ER4)
CHF 5.04+0.24 (+4.89%)
CH:ER4
Emergent Biosolutions ownership
CHF 5.04
At close:+0.24 (+4.89%)
Emergent Biosolutions (ER4) Ownership - Who Owns Emergent Biosolutions?
2 Followers
Emergent Biosolutions (ER4) Ownership Overview
- 5.29% Insiders
- 20.02% Mutual Funds
- 7.37% Other Institutional Investors
- 30.10% ETFs
- 37.22% Public Companies and Individual Investors
The ownership structure of Emergent Biosolutions (CH:ER4) stock is a mix of institutional, retail, and individual investors. Approximately 57.49% of the company’s stock is owned by Institutional Investors, 5.29% is owned by Insiders, and 37.22% is owned by Public Companies and Individual Investors.
The ownership structure of Emergent Biosolutions (CH:ER4) stock is a mix of institutional, retail, and individual investors. Approximately 57.49% of the company’s stock is owned by Institutional Investors, 5.29% is owned by Insiders, and 37.22% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Dec 08, 2025 | Ronald Richard | $262,952 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Aristeia Capital Llc | CHF345,449 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 4,716,599 | Institution | 9.17% | 28,559,007 |
| Avantis | 3,319,291 | Institution | 6.46% | 20,098,307 |
| Ishares | 3,075,029 | Institution | 5.98% | 18,619,301 |
| Vanguard | 2,715,317 | Institution | 5.28% | 16,441,244 |
| Vanguard Index Funds | 2,146,900 | Institution | 4.18% | 12,999,480 |
| Dfa | 2,018,797 | Institution | 3.93% | 12,223,816 |
| Spdr | 1,861,667 | Institution | 3.62% | 11,272,394 |
| Dfa Investment Dimensions Group Inc | 1,685,011 | Institution | 3.28% | 10,202,742 |
| Glenn R. August | 1,113,338 | Institution | 2.17% | 6,741,262 |
| Schwab Capital Trust | 911,487 | Institution | 1.77% | 5,519,054 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 2,146,900 | Institution | 4.18% | 12,999,480 |
| Dfa Investment Dimensions Group Inc | 1,685,011 | Institution | 3.28% | 10,202,742 |
| Schwab Capital Trust | 911,487 | Institution | 1.77% | 5,519,054 |
| Fidelity Salem Street Trust | 649,832 | Institution | 1.26% | 3,934,733 |
| Federated Hermes Mdt Series | 630,315 | Institution | 1.23% | 3,816,557 |
| Vanguard Horizon Funds | 528,566 | Institution | 1.03% | 3,200,467 |
| Fidelity Concord Street Trust | 486,541 | Institution | 0.95% | 2,946,006 |
| Pimco Equity Series | 350,629 | Institution | 0.68% | 2,123,059 |
| Vanguard Scottsdale Funds | 350,445 | Institution | 0.68% | 2,121,944 |
| Ancora Trust | 332,315 | Institution | 0.65% | 2,012,167 |
FAQ
Who Owns Emergent Biosolutions (CH:ER4)?
According to the latest TipRanks data, approximately 57.49% of the company's stock is held by institutional investors, 5.29% is held by insiders, and 37.22% is held by public companies and individual investors.
What percentage of Emergent Biosolutions (CH:ER4) stock is held by institutional investors?
According to the latest TipRanks data, approximately 57.49% of Emergent Biosolutions (CH:ER4) stock is held by institutional investors: 20.02% by mutual funds, 30.10% by ETFs and 7.37% by other institutional investors.
What percentage of Emergent Biosolutions (CH:ER4) stock is held by retail investors?
According to the latest TipRanks data, approximately 37.22% of Emergent Biosolutions (CH:ER4) stock is held by public companies and individual investors.
Who owns the most shares of Emergent Biosolutions (CH:ER4)?
BlackRock, Inc. owns the most shares of Emergent Biosolutions (CH:ER4).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
